GOTTSCHALK ADRIAN has filed 7 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 1075000 shares of Foghorn Therapeutics Inc. ($FHTX) on February 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2026 | Foghorn Therapeutics Inc. | $FHTX | GOTTSCHALK ADRIAN | Chief Executive Officer | A | Stock option (right to buy) | 1075000 | $5.23 | 1,075,000.0000 | 63,029,293 | 9999.99% | 1.71% |
| April 25, 2025 | Foghorn Therapeutics Inc. | $FHTX | GOTTSCHALK ADRIAN | Chief Executive Officer | G | Common Stock | 300000 | $0.00 | 511,704.0000 | 54,899,432 | 36.96% | 0.55% |
| April 25, 2025 | Foghorn Therapeutics Inc. | $FHTX | GOTTSCHALK ADRIAN | Chief Executive Officer | G | Common Stock | 300000 | $0.00 | 511,704.0000 | 54,899,432 | 141.71% | 0.55% |
| April 9, 2025 | Foghorn Therapeutics Inc. | $FHTX | GOTTSCHALK ADRIAN | Chief Executive Officer | G | Common Stock | 197906 | $0.00 | 511,704.0000 | 54,899,432 | 63.07% | 0.36% |
| April 9, 2025 | Foghorn Therapeutics Inc. | $FHTX | GOTTSCHALK ADRIAN | Chief Executive Officer | G | Common Stock | 197906 | $0.00 | 511,704.0000 | 54,899,432 | 27.89% | 0.36% |
| Jan. 22, 2025 | Foghorn Therapeutics Inc. | $FHTX | GOTTSCHALK ADRIAN | Chief Executive Officer | A | Stock Option (right to buy) | 400000 | $4.37 | 400,000.0000 | 54,899,432 | 9999.99% | 0.73% |
| Jan. 24, 2024 | Foghorn Therapeutics Inc. | $FHTX | GOTTSCHALK ADRIAN | Chief Executive Officer | A | Stock Option (right to buy) | 300000 | $3.06 | 300,000.0000 | 41,974,484 | 9999.99% | 0.71% |